Table 1. .

Antihypertensive/Lipid-Lowering Drug Treatment of Subjects in the BRIGHT Study

Medication	Na	Proportion (%)
β-Blocker	1,417	43.5
Thiazide diuretic	1,099	33.8
ACE inhibitor	1,020	31.3
Dihydropyridine Ca-channel antagonist	794	24.4
Statin	340	10.4
Loop diuretic	303	9.3
Other Ca-channel antagonist	156	4.9
α-Blocker	145	4.5
Centrally acting agent	50	1.5
A2-receptor antagonist	17	.5

^aNumber of subjects who reported each medication.